Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$342K Buy
4,763
+134
+3% +$12.6K ﹤0.01% 634
2026
Q1
$547K Sell
4,629
-1,002
-18% -$124K 0.01% 467
2025
Q4
$708K Sell
5,631
-1,141
-17% -$149K 0.01% 415
2025
Q3
$991K Sell
6,772
-1,242
-15% -$188K 0.01% 327
2025
Q2
$1.25M Sell
8,014
-1,675
-17% -$266K 0.01% 271
2025
Q1
$1.6M Buy
9,689
+1,386
+17% +$230K 0.01% 234
2024
Q4
$1.35M Sell
8,303
-190
-2% -$34K 0.01% 269
2024
Q3
$1.66M Buy
8,493
+150
+2% +$27.6K 0.01% 230
2024
Q2
$1.45M Sell
8,343
-473
-5% -$78.7K 0.01% 231
2024
Q1
$1.49M Buy
8,816
+24
+0.3% +$4.5K 0.01% 226
2023
Q4
$1.74M Buy
8,792
+52
+0.6% +$9.21K 0.02% 196
2023
Q3
$1.52M Buy
8,740
+286
+3% +$51.9K 0.02% 200
2023
Q2
$1.46M Sell
8,454
-788
-9% -$136K 0.02% 211
2023
Q1
$1.54M Buy
9,242
+1,901
+26% +$312K 0.02% 203
2022
Q4
$1.08M Buy
7,341
+371
+5% +$54.9K 0.01% 256
2022
Q3
$1.03M Sell
6,970
-428
-6% -$71.5K 0.02% 239
2022
Q2
$1.27M Sell
7,398
-185
-2% -$32K 0.02% 195
2022
Q1
$1.43M Buy
7,583
+46
+0.6% +$9.09K 0.02% 182
2021
Q4
$1.84M Buy
7,537
+723
+11% +$158K 0.02% 145
2021
Q3
$1.32M Buy
6,814
+306
+5% +$61.8K 0.02% 182
2021
Q2
$1.21M Buy
6,508
+572
+10% +$99.3K 0.02% 197
2021
Q1
$935K Buy
5,936
+1,028
+21% +$163K 0.01% 223
2020
Q4
$812K Buy
4,908
+252
+5% +$41K 0.01% 224
2020
Q3
$770K Buy
4,656
+347
+8% +$53.3K 0.01% 212
2020
Q2
$591K Sell
4,309
-488
-10% -$63.7K 0.01% 243
2020
Q1
$565K Buy
4,797
+332
+7% +$43.7K 0.01% 206
2019
Q4
$591K Sell
4,465
-131
-3% -$16.3K 0.01% 259
2019
Q3
$573K Buy
4,596
+785
+21% +$94.8K 0.01% 255
2019
Q2
$433K Buy
3,811
+315
+9% +$33K 0.01% 314
2019
Q1
$352K Buy
3,496
+271
+8% +$24.6K 0.01% 347
2018
Q4
$276K Sell
3,225
-437
-12% -$39.4K 0.01% 380
2018
Q3
$335K Buy
3,662
+161
+5% +$14.3K 0.01% 368
2018
Q2
$298K Buy
3,501
+3,167
+948% +$267K 0.01% 375
2018
Q1
$28K Sell
334
-282
-46% -$22.2K ﹤0.01% 505
2017
Q4
$44K Sell
616
-119
-16% -$8.17K ﹤0.01% 492
2017
Q3
$47K Buy
+735
New +$46K ﹤0.01% 446

Other funds holding ZTS

Greenleaf Trust's ZTS Position: Q2 2026 in Review

Greenleaf Trust increased its Zoetis (ZTS) stake by 2.9% in Q2 2026, buying an estimated $12.6K and bringing the position to 4,763 shares worth $342K. The position accounts for ﹤0.01% of the portfolio, ranked #634.

Greenleaf Trust first reported a position in ZTS in Q3 2017 and has held it in 36 quarters since. The position peaked at $1.84M in Q4 2021. 554 funds tracked by Wall St. Rank hold ZTS as of Q2 2026.

  • Greenleaf Trust held 4,763 shares of Zoetis worth $342K as of Q2 2026.
  • Greenleaf Trust bought 134 Zoetis shares in Q2 2026, an estimated $12.6K.
  • Zoetis made up ﹤0.01% of Greenleaf Trust's portfolio in Q2 2026, its #634 holding.
  • Greenleaf Trust first reported a position in Zoetis in Q3 2017 and has held it in 36 quarters since.
  • Greenleaf Trust's Zoetis position peaked at $1.84M in Q4 2021.
  • 554 funds tracked by Wall St. Rank held Zoetis as of Q2 2026.

Based on Greenleaf Trust's 13F filing for Q2 2026, filed 21 Jul 2026.